NanoScoping - About the company
NanoScoping is an unfunded company based in Palhoca (Brazil), founded in 2014 by Leticia Mazzarino, Manuel Adalberto Alfaro De Pra and maria beatriz veleirinho. It operates as a Developer of nano-capsules for the veterinary sector. NanoScoping has not raised any funding yet. The company has 471 active competitors, including 129 funded and 53 that have exited. Its top competitors include companies like Ceva, Zoetis and Liquidia.
Company Details
- Website
- nanoscoping.com.br
- Email ID
- *****@nanoscoping.com.br
- Phone Number
- +55 **********
Key Metrics
Founded Year
2014
Location
Palhoca, Brazil
Stage
Unfunded
Ranked
215th among 471 active competitors
Employee Count
25 as on Apr 30, 2026
Sign up to download NanoScoping's company profile
NanoScoping's funding and investors
NanoScoping has not raised any funding rounds yet.
NanoScoping's founders and board of directors
Founder? Claim ProfileThe founders of NanoScoping are Leticia Mazzarino, Manuel Adalberto Alfaro De Pra and maria beatriz veleirinho.
Here are the details of NanoScoping's key team members:
- Leticia Mazzarino: Co-Founder of NanoScoping.
- Manuel Adalberto Alfaro De Pra: Co-Founder of NanoScoping.
- maria beatriz veleirinho: Co-Founder of NanoScoping.
View details of NanoScoping's Founder profiles and Board Members
NanoScoping's employee count trend
NanoScoping has 25 employees as of Apr 26. Here is NanoScoping's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NanoScoping's Competitors and alternates
Top competitors of NanoScoping include Ceva, Zoetis and Liquidia. Here is the list of Top 10 competitors of NanoScoping, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Global animal health company providing innovative solutions for diverse animal species | $214M | 74/100 | ||
2nd | Zoetis 2013, Parsippany (United States), Public | Global animal health company dedicated to nurturing the world through animal care | - | 72/100 | |
3rd | Liquidia 2004, Morrisville (United States), Public | Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions | $90.3M | 68/100 | |
4th | Acorda 1995, Ardsley (United States), Acquired | Developer of therapies that restore neurological function | $66.5M | 66/100 | |
5th | Genedit 2016, Berkeley (United States), Series B | Developer of drug delivery system for genetic medicines | $93.5M | 65/100 | |
6th | Sirnaomics 2007, Gaithersburg (United States), Public | Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease | $267M | 63/100 | |
7th | Aera 2021, Boston (United States), Series B | Developer of genetic medicines across a wide range of therapeutic areas | $193M | 62/100 | |
8th | NanoSyrinx 2018, Coventry (United Kingdom), Series A | Developer of targeted intracellular delivery platform for biological molecules | $21.6M | 61/100 | |
9th | Avadel Pharmaceuticals 1990, Dublin (Ireland), Acquired | Pharma company with proprietary drug delivery tools and drug for narcolepsy | - | 59/100 | |
10th | Helex 2021, New York City (United States), Seed | Provider of next-generation gene-editing therapies | $6M | 59/100 | |
215th | NanoScoping 2014, Palhoca (Brazil), Unfunded | Developer of nano-capsules for the veterinary sector | - | - | 28/100 |
Looking for more details on NanoScoping's competitors? Click here to see the top ones
NanoScoping's Investments and acquisitions
NanoScoping has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about NanoScoping
Explore our recently published companies
- Pure Asset - United Kingdom based, Unfunded company
- Sekisan - Unfunded company
- Aseltd - Parma based, Unfunded company
- Rebitzke Ingenieurburo - Germany based, Unfunded company
- Tunnel - Unfunded company
- Starkeybutton - United Kingdom based, Unfunded company